Chemoinformaics analysis of cis-13-Eicosenoic acid
| Molecular Weight | 310.522 | nRot | 17 |
| Heavy Atom Molecular Weight | 272.218 | nRig | 2 |
| Exact Molecular Weight | 310.287 | nRing | 0 |
| Solubility: LogS | -3.238 | nHRing | 0 |
| Solubility: LogP | 7.036 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 60 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 38 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 60.3421 |
| nHD | 1 | BPOL | 38.9899 |
| QED | 0.234 |
| Synth | 2.063 |
| Natural Product Likeliness | 0.79 |
| NR-PPAR-gamma | 0.978 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.043 |
| CACO-2 | -5.073 |
| MDCK | 0.0000319 |
| BBB | 0.013 |
| PPB | 0.998495 |
| VDSS | 0.933 |
| FU | 0.00500427 |
| CYP1A2-inh | 0.24 |
| CYP1A2-sub | 0.193 |
| CYP2c19-inh | 0.253 |
| CYP2c19-sub | 0.067 |
| CYP2c9-inh | 0.138 |
| CYP2c9-sub | 0.992 |
| CYP2d6-inh | 0.021 |
| CYP2d6-sub | 0.154 |
| CYP3a4-inh | 0.082 |
| CYP3a4-sub | 0.018 |
| CL | 2.645 |
| T12 | 0.767 |
| hERG | 0.082 |
| Ames | 0.013 |
| ROA | 0.031 |
| SkinSen | 0.949 |
| Carcinogencity | 0.071 |
| EI | 0.967 |
| Respiratory | 0.889 |
| NR-Aromatase | 0.105 |
| Antiviral | No |
| Prediction | 0.564986 |